Market Research Logo

Antinuclear Antibody Test Market by Product (Reagents & Assay Kits, Systems, Software, Services), Technique (Immunofluorescence, Elisa, Multiplex), Disease (Rheumatoid Arthritis, SLE), End User (Clinical Labs, Hospitals) - Forecast to 2021

Antinuclear Antibody Test Market by Product (Reagents & Assay Kits, Systems, Software, Services), Technique (Immunofluorescence, Elisa, Multiplex), Disease (Rheumatoid Arthritis, SLE), End User (Clinical Labs, Hospitals) - Forecast to 2021

The global antinuclear antibody (ANA) testing market is expected to reach USD 1,476.1 million by 2021 from USD 823.5 million in 2016, at a CAGR of 12.4%. The global ANA testing market is segmented based on products, diseases, techniques, end users, and regions. The assay kits & reagents segment is expected to register the highest growth rate in the ANA testing market, by product, during the forecast period. The high growth in this segment is attributed to the growing number of reagent rental agreements and increasing prevalence of autoimmune diseases worldwide.

Based on end users, the ANA testing market is segmented into clinical laboratories, hospitals, POLs, and other end users. The hospitals segment is expected to account for the largest share of the market in 2016. Increasing prevalence of autoimmune diseases, coupled with the fact that most diagnostic tests are performed in hospitals or hospital-attached laboratories, will be the major factors driving the growth of this market.

North America is the largest regional segment in the global ANA testing market, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American market is primarily driven by the rising geriatric population and the growing number of people covered under medical insurance in the U.S.

In addition to comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. The company profiles in this report comprise the product portfolios, developments, and strategies adopted by players to maintain and increase their shares in the market. The abovementioned market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the ANA testing market.

The major players in this market include Alere Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), ERBA Diagnostics, Inc. (U.S.), Trinity Biotech plc (Ireland), Thermo Fisher Scientific, Inc. (U.S.), Antibodies, Inc. (U.S.), EUROIMMUN AG (Germany), Immuno Concepts (U.S.), Inova Diagnostics (U.S.), and Zeus Scientific, Inc. (U.S.).

Objectives of the Study:
To define, describe, and forecast the global antinuclear antibody testing market on the basis of product, technique, disease, and end user
To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and trends)
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia, and the Rest of the World (RoW)
To strategically analyze the market structure and profile the key players operating in the global ANA testing market and comprehensively analyze their core competencies
To track and analyze competitive developments such as new product launches, agreements, expansions, and acquisitions in the global ANA testing market

Target Audience for this Report:
ANA Testing Instrument Manufacturers and Suppliers
Clinical Laboratories
Hospitals
Pharmaceutical and Biotechnology Companies
Academic Research Institutes Related to Antinuclear Antibody Testing


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • SECONDARY DATA
      • KEY DATA FROM SECONDARY SOURCES
    • PRIMARY DATA
      • KEY DATA FROM PRIMARY SOURCES
    • MARKET SIZE ESTIMATION
      • BOTTOM-UP APPROACH
      • TOP-DOWN APPROACH
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
    • INTRODUCTION
    • CURRENT SCENARIO
    • FUTURE OUTLOOK
    • CONCLUSION
  • PREMIUM INSIGHTS
    • ANA TESTING MARKET OVERVIEW
    • LIFE CYCLE ANALYSIS, BY REGION
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET SEGMENTATION
    • MARKET DYNAMICS
      • DRIVERS
        • Table PREVALENCE DATA FOR AUTOIMMUNE DISEASES
        • Table HIGH INCIDENCE OF AUTOIMMUNE DISEASES TO DRIVE MARKET GROWTH
      • RESTRAINTS
        • Table IMPLEMENTATION OF EXCISE DUTY ON MEDICAL DEVICES IN THE U.S. TO RESTRAIN MARKET GROWTH
      • OPPORTUNITIES
        • Table GROWING DEMAND FOR LAB AUTOMATION TO OFFER MAJOR GROWTH OPPORTUNITIES
      • TREND
        • Table REAGENT RENTAL AGREEMENTS ARE AN IMPORTANT TREND IN THE ANA TESTING MARKET
  • ANTINUCLEAR ANTIBODY TESTING MARKET, BY PRODUCT
    • INTRODUCTION
      • Table ANTINUCLEAR ANTIBODY TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
    • REAGENTS & ASSAY KITS
      • Table ANA TESTING MARKET SIZE FOR REAGENTS & ASSAY KITS, BY REGION, 2014-2021 (USD MILLION)
    • SYSTEMS
      • Table ANA TESTING MARKET SIZE FOR SYSTEMS, BY REGION, 2014-2021 (USD MILLION)
    • SOFTWARE & SERVICES
      • Table ANA TESTING MARKET SIZE FOR SOFTWARE & SERVICES, BY REGION, 2014-2021 (USD MILLION)
  • ANTINUCLEAR ANTIBODY TESTING MARKET, BY TECHNIQUE
    • INTRODUCTION
      • Table ANTINUCLEAR ANTIBODY TESTING MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
    • ELISA
      • Table ANA TESTING MARKET SIZE FOR ELISA, BY REGION, 2014-2021 (USD MILLION)
    • IMMUNOFLUORESCENCE ASSAY
      • Table ANA TESTING MARKET SIZE FOR IFA, BY REGION, 2014-2021 (USD MILLION)
    • MULTIPLEX ASSAY
      • Table ANA TESTING MARKET SIZE FOR MULTIPLEX ASSAYS, BY REGION, 2014-2021 (USD MILLION)
  • ANTINUCLEAR ANTIBODY TESTING MARKET, BY DISEASE
    • INTRODUCTION
      • Table ANTINUCLEAR ANTIBODY TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
    • RHEUMATOID ARTHRITIS
      • Table ANA TESTING MARKET SIZE FOR RHEUMATOID ARTHRITIS, BY REGION, 2014-2021 (USD MILLION)
    • SYSTEMIC LUPUS ERYTHEMATOSUS
      • Table ANA TESTING MARKET SIZE FOR SYSTEMIC LUPUS ERYTHEMATOSUS, BY REGION, 2014-2021 (USD MILLION)
    • SJÖGREN'S SYNDROME
      • Table ANA TESTING MARKET SIZE FOR SJÖGREN'S SYNDROME, BY REGION, 2014-2021 (USD MILLION)
    • SCLERODERMA
      • Table ANA TESTING MARKET SIZE FOR SCLERODERMA, BY REGION, 2014-2021 (USD MILLION)
    • OTHER DISEASES
      • Table ANA TESTING MARKET SIZE FOR OTHER DISEASES, BY REGION, 2014-2021 (USD MILLION)
  • ANTINUCLEAR ANTIBODY TESTING MARKET, BY END USER
    • INTRODUCTION
      • Table ANTINUCLEAR ANTIBODY TESTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
    • HOSPITALS
      • Table GLOBAL ANTINUCLEAR ANTIBODY TESTING MARKET SIZE FOR HOSPITALS, BY TYPE, 2014-2021 (USD MILLION)
      • Table ANA TESTING MARKET SIZE FOR HOSPITALS, BY REGION, 2014-2021 (USD MILLION)
      • SMALL HOSPITALS
        • Table ANA TESTING MARKET SIZE FOR SMALL HOSPITALS, BY REGION, 2014-2021 (USD MILLION)
      • MID-SIZED HOSPITALS
        • Table ANA TESTING MARKET SIZE FOR MID-SIZED HOSPITALS, BY REGION, 2014-2021 (USD MILLION)
      • LARGE HOSPITALS
        • Table ANA TESTING MARKET SIZE FOR LARGE HOSPITALS, BY REGION, 2014-2021 (USD MILLION)
    • CLINICAL LABORATORIES
      • Table ANA TESTING MARKET SIZE FOR CLINICAL LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
    • PHYSICIAN OFFICE LABORATORIES
      • Table ANA TESTING MARKET SIZE FOR PHYSICIAN OFFICE LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
    • OTHER END USERS
      • Table ANA TESTING MARKET SIZE FOR OTHER END USERS, BY REGION, 2014-2021 (USD MILLION)
  • GEOGRAPHIC ANALYSIS
    • INTRODUCTION
      • Table ANA TESTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: ANA TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: ANA TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: ANA TESTING MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: ANA TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: ANA TESTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • U.S.
        • Table U.S.: ANA TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table U.S.: ANA TESTING MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
        • Table U.S.: ANA TESTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • CANADA
        • Table CANADA: ANA TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table CANADA: ANA TESTING MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
        • Table CANADA: ANA TESTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
    • EUROPE
      • Table EUROPE: ANA TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table EUROPE: ANA TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • Table EUROPE: ANA TESTING MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
      • Table EUROPE: ANA TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
      • Table EUROPE: ANA TESTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
    • ASIA
      • Table ASIA: ANA TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table ASIA: ANA TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • Table ASIA: ANA TESTING MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
      • Table ASIA: ANA TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
      • Table ASIA: ANA TESTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • CHINA
        • Table CHINA: ANA TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table CHINA: ANA TESTING MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
        • Table CHINA: ANA TESTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • JAPAN
        • Table JAPAN: ANA TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table JAPAN: ANA TESTING MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
        • Table JAPAN: ANA TESTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • INDIA
        • Table INDIA: ANA TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table INDIA: ANA TESTING MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
        • Table INDIA: ANA TESTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • REST OF THE ASIA (ROA)
        • Table ROA: ANA TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table ROA: ANA TESTING MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
        • Table ROA: ANA TESTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
    • REST OF THE WORLD
      • Table ROW: ANA TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table ROW: ANA TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • Table ROW: ANA TESTING MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
      • Table ROW: ANA TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
      • Table ROW: ANA TESTING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • INTRODUCTION
    • STRATEGIC OVERVIEW
    • MARKET SHARE ANALYSIS
    • COMPETITIVE SITUATION AND TRENDS
      • Table GROWTH STRATEGY MATRIX, 2013-2016
      • ACQUISITIONS
        • Table ACQUISITIONS, 2013-2016
      • AGREEMENTS
        • Table AGREEMENTS, 2013-2016
      • NEW PRODUCT LAUNCHES
        • Table NEW PRODUCT LAUNCHES, 2013-2016
      • EXPANSIONS
        • Table EXPANSIONS, 2013-2016
      • OTHER DEVELOPMENTS
        • Table OTHER DEVELOPMENTS, 2013-2016
  • COMPANY PROFILES
    • INTRODUCTION
    • THERMO FISHER SCIENTIFIC, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ALERE INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BIO-RAD LABORATORIES, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • TRINITY BIOTECH PLC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ERBA DIAGNOSTICS, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ANTIBODIES INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • EUROIMMUN AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • IMMUNO CONCEPTS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • INOVA DIAGNOSTICS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • ZEUS SCIENTIFIC, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report